Given the structural similarities between Br-Cla and Clm-1 (Scheme 1), the higher potency of the latter toward lung and gastric cancer cell lines, and the fact that it cannot undergo a chemiluminescent reaction, some doubts arose regarding the mechanism of action of both of the compounds. Here, CD300LF is linked to gastric cancer.